Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results June 6, 2012

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Omontys	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Pulmicort Flexhaler	New Drug Initial Review	Require Prior Approval	Prior Approval Requirement
Tradjenta	New Drug Appeal	Require Prior Approval	Prior Approval Required
Effient	New Drug Appeal	Require Prior Approval	Prior Approval Required
Zemplar	New Drug Appeal	Require Prior Approval	Prior Approval Required
Daliresp	New Drug Appeal	Require Prior Approval	Prior Approval Required
Xarelto	PDL Appeal	Remove Prior Approval Requirement	Preferred and Require Prior Approval
Vesicare	PDL Appeal	Require Prior Approval	Prior Approval Required

Footer